Cronos Group Inc. logo

Cronos (CRON) stock

CRON · Cronos Group Inc. · NASDAQ

Website
Market cap
$1.11B
EPS (TTM)
$0.16
Shares out
366.5M

What is the latest news on CRON stock?

PRago
Almonty Strengthens Board with Two Independent Directors and Announces Intention to Pursue a Secondary Listing on the Korean Exchange

Veteran U.S. Diplomat Dr. Eugene Bae and Seasoned Public Company CFO Jim Rudyk Join the Board; David Hanick and Andrew Frazer to Step Down Effective December 31, 2026 Almonty Industries Inc. ("Almonty" or the "Company") (NASDAQ:ALM) (Frankfurt: ALI1), a leading global producer of tungsten concentrate, today announced the appointment of Dr. Eugene Bae, Ph.D., and James (Jim) Rudyk, CPA, CA, to its Board of Directors (the "Board") as independent directors, effective immediately, and that David Hanick and Andrew Frazer will step down from the Board effective December 31, 2026. The Company also announced its intention to pursue a listing on the Korea Exchange ("KRX") in South Korea, home to A

All CRON news

When does Cronos report earnings?

Cronos last reported on Nov 5, 2026, the date it announced on Oct 8, 2026. Before that it reported on Aug 6, 2026 and May 11, 2026. On that schedule the next report would come around early February 2027, with the date usually announced about 3 weeks ahead.

CRON earnings history

Who owns the most CRON stock?

D. E. Shaw & Co., Inc. was the largest reported holder of CRON at the end of Q2 2026, with 8,840,503 shares worth $24.6 million. Next came Chescapmanager LLC ($22.1 million) and Tidal Investments LLC ($10.5 million). In all, 194 institutions reported $133.7 million of CRON in their 13F filings.

All CRON fund holders

Financial highlights

Full financials
Revenue, TTM
$271.85M
Revenue growth
+54.3%
Net income, TTM
$63.36M
Net margin
23.3%
Free cash flow, TTM
$65.38M
Cash
$411.19M

For the twelve months ended Sep 30, 2026, from SEC filings. Not investment advice.

Latest news

25 items

CRON rankings

News · 26 weeks29-17%
2026-05-31: 02026-06-07: 12026-06-14: 12026-06-21: 22026-06-28: 22026-07-05: 02026-07-12: 12026-07-19: 12026-07-26: 02026-08-02: 62026-08-09: 02026-08-16: 02026-08-23: 02026-08-30: 12026-09-06: 12026-09-13: 12026-09-20: 12026-09-27: 02026-10-04: 12026-10-11: 32026-10-18: 22026-10-25: 02026-11-01: 32026-11-08: 12026-11-15: 12026-11-22: 0
2026-05-312026-11-22
Mix1590d
  • Other4(27%)
  • SEC Filings4(27%)
  • Insider3(20%)
  • Earnings2(13%)
  • M&A1(7%)
  • Leadership1(7%)
Activity · 52 weeks7739 active days
Tap a day to see what happenedEarningsInsiderAnalystFilings and news

Cronos Group Inc. (CRON) is a Medicinal Chemicals and Botanical Products company listed on NASDAQ. In the last 30 days Quantisnow tracked 5 wire items for CRON, including 2 SEC filings, 1 earnings update and 1 insider trade. The most recent was published Nov 17, 2026.

Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness platform, PEACE NATURALS; and operates under two adult-use brands, COVE and Spinach. The company also exports dried cannabis and cannabis oils to Germany, Israel, and Australia. Cronos Group Inc. was founded in 2012 and is based in Toronto, Canada.

CRON FAQ

9 questions
  • What does Cronos Group Inc. do?
    Cronos Group Inc. operates as a cannabinoid company. It manufactures, markets, and distributes hemp-derived supplements and cosmetic products through e-commerce, retail, and hospitality partner channels under the Lord Jones and Happy Dance brands in the United States. The company is also involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. It sells cannabis and cannabis products, including dried cannabis, pre-rolls, and cannabis extracts through wholesale and direct-to-client channels under its wellness...
  • What is CRON revenue?
    Cronos Group Inc. (CRON) reported $271.85M of revenue for the twelve months ended Sep 30, 2026. That is up 54.3% from the year before. Revenue for fiscal 2025 was $193.36M.
  • Is CRON profitable?
    Yes. Cronos Group Inc. earned $63.36M in net income for the twelve months ended Sep 30, 2026, a net margin of 23.3%.
  • How much cash and debt does CRON have?
    Cronos Group Inc. reported $411.19M in cash and cash equivalents on its most recent balance sheet in SEC filings.
  • Where does CRON stock trade?
    Cronos Group Inc. (CRON) is listed on NASDAQ.
  • What sector and industry is CRON in?
    Cronos Group Inc. operates in the Health Care sector, Medicinal Chemicals and Botanical Products industry.
  • What are analysts saying about CRON?
    Across the last 8 analyst actions on Cronos Group Inc., there were 3 upgrades and 0 downgrades. The most recent action was from Canaccord Genuity: Buy on 2026-01-27. Recent price targets range from $3.00 to $4.25.
  • What companies are similar to CRON?
    Notable peers in the same industry include TLRY (Tilray Brands Inc.), CGC (Canopy Growth Corporation), ACB (Aurora Cannabis Inc.), YCBD (cbdMD Inc.). Compare CRON side-by-side with any of them on Quantisnow.
  • How can I track CRON on Quantisnow?
    Quantisnow aggregates Cronos Group Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow CRON to receive live email and push alerts on every new disclosure.

Is something on this page wrong, or out of date? Request a change